Therefore, reduced BAK and increased BCLX were reoccurring changes in acquired venetoclax resistance, although there was heterogeneity in the expression of other BCL2 family members that may also contribute to venetoclax resistance development in DLBCL. Here, BAK1 is linked to diffuse large B-cell lymphoma.